The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Cher is suing a prominent billionaire and a health care company because she allegedly felt "duped" about the value of drug stocks in which she invested, the Los Angeles Times reported.
In a lawsuit filed Friday, the entertainer accuses surgeon and entrepreneur Patrick Soon-Shiong of fraud related to investments in a Florida-based biopharmaceutical company Altor, the Times reported.
Soon-Shiong's spokesperson told the Times that the suit had "no merit." Soon-Shiong is also known for investing in Tronc Inc., which owns the Los Angeles Times, Chicago Tribune and other American news outlets.
In 2013, Cher bought her stake in Altor, then sold it back to the company early last year at $1.50 per share — "an unreasonably below-market price," the Times reported the suit says.
Yet when the singer and actress was asked to sell back her stock, she claims she wasn't informed that Altor was developing a promising drug to treat HIV/AIDS and cancer, according to the Times.
Soon-Shiong then acquired the outstanding shares of Altor, which have since skyrocketed in value. According to Cher's suit, the company is now valued at more than $1 billion.
Other defendents include Altor Acquisition LLC, Altor cofounder Hing C. Wong and Fred Middleton, a vice chairman of Altor's board.